Jolanta M Siller-Matula Selected Research

Dyspnea (Shortness of Breath)

1/2018	Ticagrelor - toward more efficient platelet inhibition and beyond.
11/2010	Ticagrelor: from discovery to Phase III clinical trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jolanta M Siller-Matula Research Topics

Disease

33	Hemorrhage 12/2023 - 11/2010
28	Acute Coronary Syndrome 04/2024 - 01/2011
19	Myocardial Infarction 04/2024 - 07/2013
15	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2014
15	Thrombosis (Thrombus) 04/2022 - 07/2013
11	Stroke (Strokes) 12/2021 - 07/2013
10	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 11/2008
8	ST Elevation Myocardial Infarction 02/2024 - 10/2014
8	Atrial Fibrillation 10/2021 - 01/2019
7	Ischemic Stroke 01/2023 - 02/2014
6	Heart Failure 11/2022 - 02/2014
6	Diabetes Mellitus 01/2022 - 07/2013
5	COVID-19 12/2023 - 11/2020
4	Aortic Valve Stenosis (Aortic Stenosis) 01/2024 - 06/2020
4	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
4	Inflammation (Inflammations) 01/2021 - 11/2010
3	Unstable Angina 11/2020 - 01/2017
2	Non-ST Elevated Myocardial Infarction 02/2024 - 11/2020
2	Neoplasms (Cancer) 10/2022 - 01/2022
2	Chronic Renal Insufficiency 01/2022 - 01/2021
2	Transient Ischemic Attack 12/2021 - 02/2014
2	Fibrosis (Cirrhosis) 11/2021 - 01/2021
2	Atherosclerosis 12/2020 - 01/2020
2	Thromboembolism 01/2019 - 08/2012
2	Dyspnea (Shortness of Breath) 01/2018 - 11/2010
2	Vascular Diseases (Vascular Disease) 11/2013 - 02/2010
1	Myocarditis (Carditis) 12/2023
1	Coronary Thrombosis 12/2023
1	Pericarditis 12/2023
1	Hypertension (High Blood Pressure) 10/2022
1	Endometriosis 10/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2022
1	Pathologic Processes 10/2022
1	Coronavirus Infections 01/2022
1	Obesity 01/2022
1	Infections 01/2022
1	Right Ventricular Dysfunction 10/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2021

Drug/Important Bio-Agent (IBA)

19	Clopidogrel (Plavix)FDA Link 04/2024 - 11/2008
16	TicagrelorIBA 04/2024 - 11/2010
12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 10/2011
12	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2011
11	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2023 - 02/2014
10	Prasugrel Hydrochloride FDA Link 12/2023 - 11/2012
9	MicroRNAs (MicroRNA)IBA 04/2023 - 01/2019
7	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
6	AnticoagulantsIBA 09/2023 - 01/2019
6	Adenosine Diphosphate (ADP)IBA 01/2020 - 08/2012
4	Vitamin K FDA Link 10/2021 - 01/2019
4	N(4)-oleylcytosine arabinosideIBA 10/2021 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 01/2021
3	Dabigatran FDA Link 10/2021 - 06/2020
3	RivaroxabanIBA 01/2021 - 01/2020
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2019 - 02/2010
3	vasodilator-stimulated phosphoproteinIBA 01/2018 - 11/2008
3	Thrombin FDA Link 08/2012 - 11/2010
2	SymportersIBA 11/2022 - 01/2021
2	SodiumIBA 11/2022 - 01/2021
2	pro-brain natriuretic peptide (1-76)IBA 11/2022 - 10/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2021 - 01/2021
2	C-Reactive ProteinIBA 01/2021 - 07/2013
2	CreatinineIBA 01/2021 - 11/2010
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2020 - 01/2019
2	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 11/2016
2	Purinergic P2Y Receptor AntagonistsIBA 11/2016 - 07/2013
2	Glycoproteins (Glycoprotein)IBA 11/2016 - 07/2013
2	Abciximab (ReoPro)FDA Link 11/2016 - 07/2013
2	von Willebrand FactorIBA 11/2012 - 05/2010
1	Indicators and Reagents (Reagents)IBA 02/2024
1	VaccinesIBA 12/2023
1	mRNA VaccinesIBA 12/2023
1	Purinergic P2Y ReceptorsIBA 12/2023
1	COVID-19 VaccinesIBA 12/2023
1	Oxygen (Dioxygen)IBA 09/2023
1	empagliflozinIBA 11/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2022
1	human MIRN320A microRNAIBA 10/2022
1	Estrogens (Estrogen)FDA Link 10/2022
1	symmetric dimethylarginineIBA 01/2022
1	sirioIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	LigandsIBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021
1	Warfarin (Coumadin)FDA LinkGeneric 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021
1	CalciumIBA 01/2021

Therapy/Procedure

29	Therapeutics 04/2024 - 10/2011
22	Percutaneous Coronary Intervention 12/2023 - 11/2008
11	Stents 04/2022 - 07/2013
6	Transcatheter Aortic Valve Replacement 01/2024 - 06/2020
4	Secondary Prevention 01/2020 - 11/2013
3	Electrodes (Electrode) 01/2017 - 09/2013
2	Length of Stay 01/2022 - 10/2021
2	Drug Tapering 01/2021 - 01/2021
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2018 - 12/2017
1	Thrombectomy 01/2023
1	Prostheses and Implants (Prosthesis) 01/2022
1	Glycemic Control 11/2021